New Funding Round Nets Ezra $21 Million

Ezra has raised $21 million from more than a baker’s dozen of investors. 

With the company’s total funding now at $41 million, the latest financing will be used to accelerate Ezra’s expansion to 20 cities and 50 locations this year throughout North America, as well as advance the use of its artificial intelligence (AI) technology by imaging centers and clinicians. Ezra leverages U.S. Food and Drug Administration (FDA)-cleared AI technology to reduce MRI scan time. 
 
The latest funding round was co-led by Healthier Capital, a venture capital that applies technology to healthcare and is led by Amir Dan Rubin, former CEO of Amazon’s One Medical. FirstMark Capital co-led the round, with participation from Allianz Life Ventures (the venture capital arm of Allianz Life Insurance Company of North America); the Schwarzman family; former Chairman of England’s National Health Service (NHS) Lord David Prior; Gaingels; Republic; and Mana Ventures. Existing investors Credo Ventures, Seedcamp, LDV Capital, Accomplice, Founders Future, Vlad Tenev, Anne Wojcicki, and Esther Dyson also participated. Rubin will also join Ezra’s Board of Directors.
 
“Five years ago, Ezra pioneered the full body MRI space by being the first company in the U.S. to offer fast, accurate, affordable, AI-powered full body MRI scans. We have since scanned thousands of people and have helped individuals identify cancer and over 500 other types of diseases early,” Ezra Founder/CEO Emi Gal said. “This year, 10 million people will receive late-stage cancer diagnoses, with survival chances below 20%. At Ezra, we aim to detect cancer early for these 10 million people, improving their chance of getting cured. I’m thrilled to join forces with Healthier Capital and Amir Dan Rubin to further our goal of making cancer screening more affordable and accessible.”
 
This new investment follows an impactful year at Ezra. The company doubled its revenue in 2023, and received FDA clearance for Ezra Flash AI, providing the world with its first 30-minute full body MRI scan enhanced by AI, according to Ezra executives. AI innovations have enabled Ezra to reduce the price of an Ezra full body MRI scan by 40%,.
 
“At Healthier Capital we are excited to see how the Ezra team is leveraging AI in imaging to significantly increase affordability, access and outcomes,” Healthier Capital CEO/Managing Partner said Amir Dan Rubin said.
 
“As a long-standing board member and investor in Ezra, I have witnessed first-hand the progress and impact this company has made in the field of early cancer detection,” FirstMark Capital Co-Founder/Partner Rick Heitzmann stated. “Ezra’s recent advancements in AI-powered full body MRI scans represent a significant leap in making cancer screening more accessible and affordable, and I am proud to be part of this mission to detect cancer early.”
 
Ezra currently operates at 18 locations in New York, New Jersey, Los Angeles, Irvine (Calif.), San Francisco, Miami, and Las Vegas.
 
Ezra is a New York-based healthcare AI company developing medical imaging and AI tech for full-body cancer screening. Founded in 2018 by Gal, Ezra monitors for possible cancer and more than 500+ conditions in up to 13 organs, enabling clinicians to detect potential cancer and other diseases at an earlier stage through preventative, proactive, and ongoing cancer screening via the company’s Full Body MRI scan.